TechFlow Logo
Login/ Sign up
ETH Gas
Gwei
Fear
gas
7x24hNews

Sonnet Biotherapeutics receives shareholder approval to merge with Hyperliquid Strategies Inc

2025.12.02 - 14:20
Exclusive
Share

TechFlow news, December 2: According to market information, Sonnet Biotherapeutics, a Nasdaq-listed biotechnology company, has received shareholder approval for a proposed business combination with Hyperliquid Strategies Inc.

Previous report: Hyperliquid Strategies filed an S-1 form aiming to raise up to $1 billion, potentially used to purchase HYPE tokens.

Add to Favorites
Share to Social Media